Biotech Inactive 20-F2007 FY Annual report (foreign)

Filed: 28 Sep 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: accrual, addressed, adjustment, adult, agenda, antibiotic, architecture, Arvana, assembly, Avigo, bifurcation, black, blisterpacked, Bogota, bottom, box, brevity, broadly, budget, Burnaby, CA, Cinnamon, clarity, classed, Colombian, constrained, correctly, Costa, Council, CTF, Description, disappointed, discretion, dispute, duringthe, East, Ecuador, elevated, embedded, Fax, firm, fit, founding, freestanding, hired, historical, HLB, hybrid, Identity, insider, Jang, Kingsway, lack, landscape, life, member, MetroTower, Middle, mortgage, Negotiate, ofBiotech, ofInternational, Ontario, orderly, Orex, Organizational, Orko, OTCBB, overfunded, partially, postretirement, publicly, quorum, rebounded, redemption, reinstatement, release, repeat, reversal, Rica, sake, salary, Secretary, securitization, securitized, Silver, simplify, size, small, torelated, Toronto, transfer, transition, trend, typified, uncertain, underfunded, ve, Verb, waived, warning, Willoughby

Removed: approve, background, book, calculated, calculation, care, closure, decided, direct, ecured, EITF, extinguishment, extraordinary, Food, fulfilled, hnology, incentive, initially, label, laboratory, ll, ly, minimal, Modification, mpact, Overwaitea, permanent, program, prove, reactivate, remuneration, repaid, Rescission, restructuring, returned, Segmented, steadily, tec, transactio, Venezuela, wi, writedown

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Biotech similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350 as adopted pursuant to Section 906
Of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Biotech Holdings Ltd. (the "Company") on Form 20-F for the year ended March 31, 2007, as filed with the Securities Exchange Commission on the date hereof (the "REPORT"), I, Robert B. Rieveley, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September __25___, 2007

/s/ Robert B. Rieveley
______________________________________
Robert B. Rieveley, President and C.E.O.

CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350 as adopted pursuant to Section 906
Of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Biotech Holdings Ltd. (the "Company") on Form 20-F for the year ended March 31, 2007, as filed with the Securities Exchange Commission on the date hereof (the "REPORT"), I, Lorne D. Brown, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September _25__, 2007

/s/ Lorne D. Brown
______________________________________
Lorne D. Brown, C.F.O.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.